Clinical trial
BMS-188797 in Treating Patients With Advanced Solid Tumors That Have Not…
NCT00005611 · H. Lee Moffitt Cancer Center and Research Institute, Other · Unknown status
Key facts
| NCT number | NCT00005611 |
|---|---|
| Title | BMS-188797 in Treating Patients With Advanced Solid Tumors That Have Not Responded to Previous Treatment |
| Official title | Phase I Study of BMS-188797 in Patients With Advanced Malignancies |
| Lead sponsor | H. Lee Moffitt Cancer Center and Research Institute, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Unknown status |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Unspecified Adult Solid Tumor, Protocol Specific |
| Intervention type | Drug |
| Interventions | BMS-188797 |
| First posted | Jul 26, 2004 |
| Last update posted | Jul 24, 2008 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: